Clinical Trial Update: Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD) [NA]

View source ↗

Summary

A clinical trial updating on the mechanisms of clonal and non-clonal cytopenia after CAR-T cell therapy in patients with multiple myeloma or CD19-positive lymph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoproliferative Disorder
• Multiple Myeloma

Drugs mentioned

• CAR-T therapy (Chimeric antigen receptor T-cell therapy)

Snippet

Sponsor: Mayo Clinic | Conditions: Lymphoproliferative Disorder, Multiple Myeloma | NA | Status: RECRUITING